View in EDS

Phase II Clinical Trial of Trametinib and Low-Dose Dabrafenib in Advanced, Previously Treated BRAF V600 /NRAS Q61 Wild-Type Melanoma (TraMel-WT).

Saved in:
Bibliographic Details
Title: Phase II Clinical Trial of Trametinib and Low-Dose Dabrafenib in Advanced, Previously Treated BRAF V600 /NRAS Q61 Wild-Type Melanoma (TraMel-WT).
Authors: Awada, Gil1 (AUTHOR) Gil.Awada@uzbrussel.be, Dirven, Iris1 (AUTHOR), Schwarze, Julia Katharina1 (AUTHOR), Tijtgat, Jens1 (AUTHOR), Fasolino, Giuseppe2 (AUTHOR), Kockx, Mark3 (AUTHOR), Neyns, Bart1 (AUTHOR)
Source: JCO Precision Oncology. 12/1/2024, Vol. 8, p1-16. 16p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 180831611
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase II Clinical Trial of Trametinib and Low-Dose Dabrafenib in Advanced, Previously Treated BRAF V600 /NRAS Q61 Wild-Type Melanoma (TraMel-WT).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Awada%2C+Gil%22">Awada, Gil</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> Gil.Awada@uzbrussel.be</i><br /><searchLink fieldCode="AR" term="%22Dirven%2C+Iris%22">Dirven, Iris</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schwarze%2C+Julia+Katharina%22">Schwarze, Julia Katharina</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tijtgat%2C+Jens%22">Tijtgat, Jens</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fasolino%2C+Giuseppe%22">Fasolino, Giuseppe</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kockx%2C+Mark%22">Kockx, Mark</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Neyns%2C+Bart%22">Neyns, Bart</searchLink><relatesTo>1</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22JCO+Precision+Oncology%22">JCO Precision Oncology</searchLink>. 12/1/2024, Vol. 8, p1-16. 16p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=180831611
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/PO.23.00493
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 16
        StartPage: 1
    Titles:
      – TitleFull: Phase II Clinical Trial of Trametinib and Low-Dose Dabrafenib in Advanced, Previously Treated BRAF V600 /NRAS Q61 Wild-Type Melanoma (TraMel-WT).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Awada, Gil
      – PersonEntity:
          Name:
            NameFull: Dirven, Iris
      – PersonEntity:
          Name:
            NameFull: Schwarze, Julia Katharina
      – PersonEntity:
          Name:
            NameFull: Tijtgat, Jens
      – PersonEntity:
          Name:
            NameFull: Fasolino, Giuseppe
      – PersonEntity:
          Name:
            NameFull: Kockx, Mark
      – PersonEntity:
          Name:
            NameFull: Neyns, Bart
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 12/1/2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 24734284
          Numbering:
            – Type: volume
              Value: 8
          Titles:
            – TitleFull: JCO Precision Oncology
              Type: main
ResultId 1